Newsroom
July 29, 2021
Loss of smell also observed in Argentine sample. Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu DENVER, Colo. (July 29, 2021) — In a sample of over 400 older adults in Argentina who had recovered from COVID-19, more than 60% displayed some degree of cognitive impairment, a researcher from The University of Texas Health Science Center at San […]
July 27, 2021
Dr. Gabriel de Erausquin and Dr. Sudha Seshadri, Neurology/Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, and Dr. Monica Verduzco-Gutierrez, Rehabilitation Medicine, are quoted in this NPR story and share their research findings of how COVID-19 affects the brain. Listen here
July 8, 2021
Dr. Megan Sullivan, School of Dentistry, is quoted in this story and discusses the importance of oral health. Sullivan said dentists are trained not to just treat your teeth, but also to assess your overall health and share any concerns they may see from your oral health with you. Read story.
June 17, 2021
Framingham Heart Study analysis finds association in APOE ε4 allele carriers. Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (June 17, 2021) — Middle-aged people with depressive symptoms who carry a genetic variation called apolipoprotein (APOE) ε4 may be more at risk to develop tau protein accumulations in the brain’s emotion- and memory-controlling regions, a new […]
June 9, 2021
The U.S. Food and Drug Administration (FDA) on Monday, June 7, approved the drug aducanumab for the treatment of Alzheimer’s disease, which affects 6.2 million Americans. Sudha Seshadri, MD, professor of neurology at UT Health San Antonio and director of the university’s Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, issued the following statement: “We are excited that a drug, aducanumab (Aduhelm, from Biogen), has been approved by the FDA for treatment of persons with early symptoms due to Alzheimer’s disease. This is the first new drug approved for Alzheimer’s in two decades.”
April 30, 2021
Detecting dementia earlier — and at much lower cost — is the goal of a San Antonio Medical Foundation grant awarded to The University of Texas Health Science Center at San Antonio (UT Health San Antonio), The University of Texas at San Antonio (UTSA) and the South Texas Veterans Health Care System. The project’s impetus […]
